Current Status of Diagnosis, Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis
- Sponsor
- Chu Hongling
- Study ID
- NCT06629623
- Status
- Enrolling By Invitation
Conditions
- Idiopathic Pulmonary Fibrosis
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Accepted
Interventions
- No intervention — OTHERNo intervention
Study Details
The goal of this observational study is to explore current status of diagnosis, treatment and quality of life for patients with idiopathic pulmonary fibrosis. It aims to integrate qualitative and quantitative data to describe the distribution of perspective, experience, patient journey, treatment, expectation and quality of life for patients with idiopathic pulmonary fibrosis. Participants will be invited to participate the interview, and answer quantitative survey questions about their quality of life.
Key Dates
- First listed
- Oct 8, 2024
- Start date
- Jul 30, 2024
- Status verified
- Sep 2024
- Primary completion
- Dec 30, 2025
- Completion
- Dec 30, 2025
Study Design
- Enrollment
- 310 participants (estimated)
Arms
- Arm: Patients with IPF
Primary Outcome Measure
Unmet patient needs [ Time Frame: At beginning of study to explore by qualitative study, sequentially follow up at 6 month by quantitative survey ]
Related Studies
- Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)Recruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- A Study of the Natural Progression of Interstitial Lung Disease (ILD)Recruiting · University of Chicago · Chicago, Illinois
- Mechanisms of Familial Pulmonary FibrosisRecruiting · Vanderbilt University Medical Center · Nashville, Tennessee
- Lung and Bone Marrow Transplantation for Lung and Bone Marrow FailurePHASE1/PHASE2 · Recruiting · Paul Szabolcs · Pittsburgh, Pennsylvania